{
  "DOI": "10.1186/s40246-022-00435-7",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-022-00435-7",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBackground\u003c/jats:title\u003e\n                \u003cjats:p\u003eFor the majority of individuals with early-onset or familial breast cancer referred for genetic testing, the genetic basis of their familial breast cancer remains unexplained. To identify novel germline variants associated with breast cancer predisposition, whole-exome sequencing (WES) was performed.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eMethods\u003c/jats:title\u003e\n                \u003cjats:p\u003eWES on 290 \u003cjats:italic\u003eBRCA1/BRCA2\u003c/jats:italic\u003e-negative Singaporeans with early-onset breast cancer and/or a family history of breast cancer was done. Case–control analysis against the East-Asian subpopulation (EAS) from the Genome Aggregation Database (gnomAD) identified variants enriched in cases, which were further selected by occurrence in cancer gene databases. Variants were further evaluated in repeated case–control analyses using a second case cohort from the database of Genotypes and Phenotypes (dbGaP) comprising 466 early-onset breast cancer patients from the United States, and a Singapore SG10K_Health control cohort.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eResults\u003c/jats:title\u003e\n                \u003cjats:p\u003eForty-nine breast cancer-associated germline pathogenic variants in 37 genes were identified in Singapore cases versus gnomAD (EAS). Compared against SG10K_Health controls, 13 of 49 variants remain significantly enriched (False Discovery Rate (FDR)-adjusted \u003cjats:italic\u003ep\u003c/jats:italic\u003e \u0026lt; 0.05). Comparing these 49 variants in dbGaP cases against gnomAD (EAS) and SG10K_Health controls revealed 23 concordant variants that were significantly enriched (FDR-adjusted \u003cjats:italic\u003ep\u003c/jats:italic\u003e \u0026lt; 0.05). Fourteen variants were consistently enriched in breast cancer cases across all comparisons (FDR-adjusted \u003cjats:italic\u003ep\u003c/jats:italic\u003e \u0026lt; 0.05). Seven variants in \u003cjats:italic\u003eGPRIN2, NRG1, MYO5A, CLIP1\u003c/jats:italic\u003e, \u003cjats:italic\u003eCUX1, GNAS\u003c/jats:italic\u003e and \u003cjats:italic\u003eMGA\u003c/jats:italic\u003e were confirmed by Sanger sequencing.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eConclusions\u003c/jats:title\u003e\n                \u003cjats:p\u003eIn conclusion, we have identified pathogenic variants in genes associated with breast cancer predisposition. Importantly, many of these variants were significant in a second case cohort from dbGaP, suggesting that the strategy of using case–control analysis to select variants could potentially be utilized for identifying variants associated with cancer susceptibility.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e",
  "alternative-id": [
    "435"
  ],
  "article-number": "61",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "15 August 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "14 November 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "23 November 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Date",
      "name": "change_date",
      "order": 4,
      "value": "19 December 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Type",
      "name": "change_type",
      "order": 5,
      "value": "Correction"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Details",
      "name": "change_details",
      "order": 6,
      "value": "A Correction to this paper has been published:"
    },
    {
      "URL": "https://doi.org/10.1186/s40246-022-00443-7",
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Details",
      "name": "change_details",
      "order": 7,
      "value": "https://doi.org/10.1186/s40246-022-00443-7"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Written informed consent was obtained from all participants and the study was approved by the SingHealth Centralised Institutional Review Board (CIRB Ref: 2018/2147)."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "P.A. reports receiving travel support and/or honoraria from AstraZeneca, DKSH, Eisai, Bristol Myers Squibb, Lilly, Novartis, Pfizer, Roche, and MSD, all of which are outside the submitted work. M.-H.T. reports being a director, shareholder, and Chief Executive Officer of Lucence, outside of the submitted work. S.-C.L. reports grant support/research collaborations with Pfizer, Eisai, Taiho, ACT Genomics, Bayer, and MSD; advisory board/speaker invitations from Pfizer, Novartis, Astra Zeneca, ACT Genomics, Eli Lilly, MSD, Roche, Eisai and Daiichi-Sankyo; conference support from Amgen, Pfizer and Roche, all of which are outside the submitted work. All other authors declare that they have no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Lee",
      "given": "Ning Yuan",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Hum",
      "given": "Melissa",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Amali",
      "given": "Aseervatham Anusha",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lim",
      "given": "Wei Kiat",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wong",
      "given": "Matthew",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Myint",
      "given": "Matthew Khine",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tay",
      "given": "Ru Jin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ong",
      "given": "Pei-Yi",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Samol",
      "given": "Jens",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lim",
      "given": "Chia Wei",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ang",
      "given": "Peter",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tan",
      "given": "Min-Han",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lee",
      "given": "Soo-Chin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lee",
      "given": "Ann S. G.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2022,
        11,
        24
      ]
    ],
    "date-time": "2022-11-24T18:32:04Z",
    "timestamp": 1669314724000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        12,
        19
      ]
    ],
    "date-time": "2022-12-19T06:06:18Z",
    "timestamp": 1671429978000
  },
  "funder": [
    {
      "DOI": "10.13039/501100001348",
      "award": [
        "IAF-ICP: I1801E0021",
        "IAF-ICP: I1801E0021",
        "IAF-ICP: I1801E0021",
        "IAF-ICP: I1801E0021"
      ],
      "doi-asserted-by": "publisher",
      "name": "Agency for Science, Technology and Research"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        19
      ]
    ],
    "date-time": "2024-04-19T08:18:04Z",
    "timestamp": 1713514684342
  },
  "is-referenced-by-count": 5,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2022,
        11,
        23
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2022,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            11,
            23
          ]
        ],
        "date-time": "2022-11-23T00:00:00Z",
        "timestamp": 1669161600000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            11,
            23
          ]
        ],
        "date-time": "2022-11-23T00:00:00Z",
        "timestamp": 1669161600000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-022-00435-7.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-022-00435-7/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-022-00435-7.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2022,
        11,
        23
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2022,
        11,
        23
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.3322/caac.21660",
      "author": "H Sung",
      "doi-asserted-by": "publisher",
      "first-page": "209",
      "issue": "3",
      "journal-title": "CA Cancer J Clin",
      "key": "435_CR1",
      "unstructured": "Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.",
      "volume": "71",
      "year": "2021"
    },
    {
      "DOI": "10.1146/annurev.genet.32.1.95",
      "author": "N Rahman",
      "doi-asserted-by": "publisher",
      "first-page": "95",
      "journal-title": "Annu Rev Genet",
      "key": "435_CR2",
      "unstructured": "Rahman N, Stratton MR. The genetics of breast cancer susceptibility. Annu Rev Genet. 1998;32:95–121.",
      "volume": "32",
      "year": "1998"
    },
    {
      "DOI": "10.6004/jnccn.2020.0017",
      "author": "MB Daly",
      "doi-asserted-by": "publisher",
      "first-page": "380",
      "issue": "4",
      "journal-title": "J Natl Compr Cancer Netw",
      "key": "435_CR3",
      "unstructured": "Daly MB, Pilarski R, Yurgelun MB, Berry MP, Buys SS, Dickson P, et al. NCCN guidelines insights: genetic/familial high-risk assessment: breast, ovarian, and pancreatic, Version 1.2020. J Natl Compr Cancer Netw. 2020;18(4):380–91.",
      "volume": "18",
      "year": "2020"
    },
    {
      "DOI": "10.1007/s00439-013-1299-y",
      "author": "L Melchor",
      "doi-asserted-by": "publisher",
      "first-page": "845",
      "issue": "8",
      "journal-title": "Hum Genet",
      "key": "435_CR4",
      "unstructured": "Melchor L, Benítez J. The complex genetic landscape of familial breast cancer. Hum Genet. 2013;132(8):845–63.",
      "volume": "132",
      "year": "2013"
    },
    {
      "DOI": "10.1038/nrc.2016.72",
      "author": "FC Nielsen",
      "doi-asserted-by": "publisher",
      "first-page": "599",
      "issue": "9",
      "journal-title": "Nat Rev Cancer",
      "key": "435_CR5",
      "unstructured": "Nielsen FC, van Overeem HT, Sørensen CS. Hereditary breast and ovarian cancer: new genes in confined pathways. Nat Rev Cancer. 2016;16(9):599–612.",
      "volume": "16",
      "year": "2016"
    },
    {
      "DOI": "10.1073/pnas.1407909111",
      "author": "JI Kiiski",
      "doi-asserted-by": "publisher",
      "first-page": "15172",
      "issue": "42",
      "journal-title": "Proc Natl Acad Sci",
      "key": "435_CR6",
      "unstructured": "Kiiski JI, Pelttari LM, Khan S, Freysteinsdottir ES, Reynisdottir I, Hart SN, et al. Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer. Proc Natl Acad Sci. 2014;111(42):15172–7.",
      "volume": "111",
      "year": "2014"
    },
    {
      "DOI": "10.1002/humu.23017",
      "author": "MR Chandler",
      "doi-asserted-by": "publisher",
      "first-page": "835",
      "issue": "9",
      "journal-title": "Hum Mutat",
      "key": "435_CR7",
      "unstructured": "Chandler MR, Bilgili EP, Merner ND. A review of whole-exome sequencing efforts toward hereditary breast cancer susceptibility gene discovery. Hum Mutat. 2016;37(9):835–46.",
      "volume": "37",
      "year": "2016"
    },
    {
      "key": "435_CR8",
      "unstructured": "Precision Health Research, Singapore SG10K. Precision Health Research, Singapore (PRECISE) [Internet]. [cited 2021 Jun 24]. Available from: https://web.archive.org/web/20210624043126/https://www.npm.sg/collaborate/partners/sg10k/"
    },
    {
      "DOI": "10.1186/s13059-018-1612-0",
      "author": "D Repana",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "issue": "1",
      "journal-title": "Genome Biol",
      "key": "435_CR9",
      "unstructured": "Repana D, Nulsen J, Dressler L, Bortolomeazzi M, Venkata SK, Tourna A, et al. The Network of Cancer Genes (NCG): a comprehensive catalogue of known and candidate cancer genes from cancer sequencing screens. Genome Biol. 2019;20(1):1.",
      "volume": "20",
      "year": "2019"
    },
    {
      "DOI": "10.1038/sj.bjc.6601894",
      "author": "S Bamford",
      "doi-asserted-by": "publisher",
      "first-page": "355",
      "issue": "2",
      "journal-title": "Br J Cancer",
      "key": "435_CR10",
      "unstructured": "Bamford S, Dawson E, Forbes S, Clements J, Pettett R, Dogan A, et al. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer. 2004;91(2):355–8.",
      "volume": "91",
      "year": "2004"
    },
    {
      "DOI": "10.1038/s41588-019-0572-y",
      "author": "F Dietlein",
      "doi-asserted-by": "publisher",
      "first-page": "208",
      "issue": "2",
      "journal-title": "Nat Genet",
      "key": "435_CR11",
      "unstructured": "Dietlein F, Weghorn D, Taylor-Weiner A, Richters A, Reardon B, Liu D, et al. Identification of cancer driver genes based on nucleotide context. Nat Genet. 2020;52(2):208–18.",
      "volume": "52",
      "year": "2020"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-19-0191",
      "author": "MR Jones",
      "doi-asserted-by": "publisher",
      "first-page": "4674",
      "issue": "15",
      "journal-title": "Clin Cancer Res",
      "key": "435_CR12",
      "unstructured": "Jones MR, Williamson LM, Topham JT, Lee MKC, Goytain A, Ho J, et al. NRG1 gene fusions are recurrent, clinically actionable gene rearrangements in KRAS wild-type pancreatic ductal adenocarcinoma. Clin Cancer Res. 2019;25(15):4674–81.",
      "volume": "25",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.humpath.2018.06.002",
      "author": "N Sato",
      "doi-asserted-by": "publisher",
      "first-page": "113",
      "journal-title": "Hum Pathol",
      "key": "435_CR13",
      "unstructured": "Sato N, Fujishima F, Nakamura Y, Aoyama Y, Onodera Y, Ozawa Y, et al. Myosin 5a regulates tumor migration and epithelial-mesenchymal transition in esophageal squamous cell carcinoma: utility as a prognostic factor. Hum Pathol. 2018;80:113–22.",
      "volume": "80",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41586-021-04135-5",
      "author": "H Izumi",
      "doi-asserted-by": "publisher",
      "first-page": "319",
      "issue": "7888",
      "journal-title": "Nature",
      "key": "435_CR14",
      "unstructured": "Izumi H, Matsumoto S, Liu J, Tanaka K, Mori S, Hayashi K, et al. The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer. Nature. 2021;600(7888):319–23.",
      "volume": "600",
      "year": "2021"
    },
    {
      "DOI": "10.3390/cancers13122953",
      "author": "ZM Ramdzan",
      "doi-asserted-by": "publisher",
      "first-page": "552",
      "issue": "12",
      "journal-title": "Cancers (Basel)",
      "key": "435_CR15",
      "unstructured": "Ramdzan ZM, Vickridge E, Faraco CCF, Nepveu A. CUT domain proteins in DNA repair and cancer. Cancers (Basel). 2021;13(12):552.",
      "volume": "13",
      "year": "2021"
    },
    {
      "DOI": "10.1007/s12094-019-02042-w",
      "author": "X Jin",
      "doi-asserted-by": "publisher",
      "first-page": "1207",
      "issue": "9",
      "journal-title": "Clin Transl Oncol",
      "key": "435_CR16",
      "unstructured": "Jin X, Zhu L, Cui Z, Tang J, Xie M, Ren G. Elevated expression of GNAS promotes breast cancer cell proliferation and migration via the PI3K/AKT/Snail1/E-cadherin axis. Clin Transl Oncol. 2019;21(9):1207–19.",
      "volume": "21",
      "year": "2019"
    },
    {
      "DOI": "10.1038/nature13385",
      "author": "Cancer Genome Atlas Research Network",
      "doi-asserted-by": "publisher",
      "first-page": "543",
      "issue": "7511",
      "journal-title": "Nature",
      "key": "435_CR17",
      "unstructured": "Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014;511(7511):543–50.",
      "volume": "511",
      "year": "2014"
    },
    {
      "DOI": "10.1093/nar/gkaa1100",
      "author": "UniProt Consortium",
      "doi-asserted-by": "publisher",
      "first-page": "D480",
      "issue": "D1",
      "journal-title": "Nucleic Acids Res",
      "key": "435_CR18",
      "unstructured": "UniProt Consortium. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 2021;49(D1):D480–9.",
      "volume": "49",
      "year": "2021"
    },
    {
      "DOI": "10.1021/cr400525m",
      "author": "R van der Lee",
      "doi-asserted-by": "publisher",
      "first-page": "6589",
      "issue": "13",
      "journal-title": "Chem Rev",
      "key": "435_CR19",
      "unstructured": "van der Lee R, Buljan M, Lang B, Weatheritt RJ, Daughdrill GW, Dunker AK, et al. Classification of intrinsically disordered regions and proteins. Chem Rev. 2014;114(13):6589–631.",
      "volume": "114",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.jmb.2018.06.051",
      "author": "C Li",
      "doi-asserted-by": "publisher",
      "first-page": "3200",
      "issue": "18",
      "journal-title": "J Mol Biol",
      "key": "435_CR20",
      "unstructured": "Li C, Clark LVT, Zhang R, Porebski BT, McCoey JM, Borg NA, et al. Structural capacitance in protein evolution and human diseases. J Mol Biol. 2018;430(18):3200–17.",
      "volume": "430",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.cancergen.2017.11.011",
      "author": "N Khalilipour",
      "doi-asserted-by": "publisher",
      "first-page": "46",
      "journal-title": "Cancer Genet",
      "key": "435_CR21",
      "unstructured": "Khalilipour N, Baranova A, Jebelli A, Heravi-Moussavi A, Bruskin S, Abbaszadegan MR. Familial esophageal squamous cell carcinoma with damaging rare/germline mutations in KCNJ12/KCNJ18 and GPRIN2 genes. Cancer Genet. 2018;221:46–52.",
      "volume": "221",
      "year": "2018"
    },
    {
      "DOI": "10.1038/ng.810",
      "author": "X Wei",
      "doi-asserted-by": "publisher",
      "first-page": "442",
      "issue": "5",
      "journal-title": "Nat Genet",
      "key": "435_CR22",
      "unstructured": "Wei X, Walia V, Lin JC, Teer JK, Prickett TD, Gartner J, et al. Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat Genet. 2011;43(5):442–6.",
      "volume": "43",
      "year": "2011"
    },
    {
      "DOI": "10.1101/gr.229102",
      "author": "WJ Kent",
      "doi-asserted-by": "publisher",
      "first-page": "996",
      "issue": "6",
      "journal-title": "Genome Res",
      "key": "435_CR23",
      "unstructured": "Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res. 2002;12(6):996–1006.",
      "volume": "12",
      "year": "2002"
    },
    {
      "DOI": "10.1016/S1470-2045(21)00028-0",
      "author": "SJ Bowden",
      "doi-asserted-by": "publisher",
      "first-page": "548",
      "issue": "4",
      "journal-title": "Lancet Oncol",
      "key": "435_CR24",
      "unstructured": "Bowden SJ, Bodinier B, Kalliala I, Zuber V, Vuckovic D, Doulgeraki T, et al. Genetic variation in cervical preinvasive and invasive disease: a genome-wide association study. Lancet Oncol. 2021;22(4):548–57.",
      "volume": "22",
      "year": "2021"
    },
    {
      "DOI": "10.1007/s10549-011-1765-y",
      "author": "V Varadi",
      "doi-asserted-by": "publisher",
      "first-page": "311",
      "issue": "1",
      "journal-title": "Breast Cancer Res Treat",
      "key": "435_CR25",
      "unstructured": "Varadi V, Bevier M, Grzybowska E, Johansson R, Enquist-Olsson K, Henriksson R, et al. Genetic variation in ALCAM and other chromosomal instability genes in breast cancer survival. Breast Cancer Res Treat. 2012;131(1):311–9.",
      "volume": "131",
      "year": "2012"
    },
    {
      "DOI": "10.1038/npjgenmed.2015.3",
      "author": "ESY Wong",
      "doi-asserted-by": "publisher",
      "first-page": "15003",
      "journal-title": "NPJ Genomic Med",
      "key": "435_CR26",
      "unstructured": "Wong ESY, Shekar S, Met-Domestici M, Chan C, Sze M, Yap YS, et al. Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore. NPJ Genomic Med. 2016;1:15003.",
      "volume": "1",
      "year": "2016"
    },
    {
      "DOI": "10.1200/JCO.20.02785",
      "author": "AW Kurian",
      "doi-asserted-by": "publisher",
      "first-page": "1631",
      "issue": "15",
      "journal-title": "J Clin Oncol",
      "key": "435_CR27",
      "unstructured": "Kurian AW, Ward KC, Abrahamse P, Bondarenko I, Hamilton AS, Deapen D, et al. Time trends in receipt of germline genetic testing and results for women diagnosed with breast cancer or ovarian cancer, 2012–2019. J Clin Oncol. 2021;39(15):1631–40.",
      "volume": "39",
      "year": "2021"
    },
    {
      "DOI": "10.1371/journal.pone.0055681",
      "author": "FJ Gracia-Aznarez",
      "doi-asserted-by": "publisher",
      "first-page": "e55681",
      "issue": "2",
      "journal-title": "PLoS One.",
      "key": "435_CR28",
      "unstructured": "Gracia-Aznarez FJ, Fernandez V, Pita G, Peterlongo P, Dominguez O, de la Hoya M, et al. Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles. PLoS One. 2013;8(2):e55681.",
      "volume": "8",
      "year": "2013"
    },
    {
      "DOI": "10.3389/fgene.2019.01005",
      "author": "S Glentis",
      "doi-asserted-by": "publisher",
      "first-page": "1005",
      "journal-title": "Front Genet",
      "key": "435_CR29",
      "unstructured": "Glentis S, Dimopoulos AC, Rouskas K, Ntritsos G, Evangelou E, Narod SA, et al. Exome sequencing in BRCA1- and BRCA2-negative greek families identifies MDM1 and NBEAL1 as candidate risk genes for hereditary breast cancer. Front Genet. 2019;10:1005.",
      "volume": "10",
      "year": "2019"
    },
    {
      "DOI": "10.1186/s12885-019-5494-7",
      "author": "RB Shahi",
      "doi-asserted-by": "publisher",
      "first-page": "313",
      "issue": "1",
      "journal-title": "BMC Cancer",
      "key": "435_CR30",
      "unstructured": "Shahi RB, De Brakeleer S, Caljon B, Pauwels I, Bonduelle M, Joris S, et al. Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families. BMC Cancer. 2019;19(1):313.",
      "volume": "19",
      "year": "2019"
    },
    {
      "DOI": "10.3390/genes13081296",
      "author": "D BenAyed-Guerfali",
      "doi-asserted-by": "publisher",
      "first-page": "1296",
      "issue": "8",
      "journal-title": "Genes (Basel)",
      "key": "435_CR31",
      "unstructured": "BenAyed-Guerfali D, Kifagi C, BenKridis-Rejeb W, Ammous-Boukhris N, Ayedi W, Khanfir A, et al. The identification by exome sequencing of candidate genes in BRCA-negative tunisian patients at a high risk of hereditary breast/ovarian cancer. Genes (Basel). 2022;13(8):1296.",
      "volume": "13",
      "year": "2022"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-07-0403",
      "author": "P Ang",
      "doi-asserted-by": "publisher",
      "first-page": "2276",
      "issue": "11",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "435_CR32",
      "unstructured": "Ang P, Lim IHK, Lee T-C, Luo J-T, Ong DCT, Tan PH, et al. BRCA1 and BRCA2 mutations in an Asian clinic-based population detected using a comprehensive strategy. Cancer Epidemiol Biomarkers Prev. 2007;16(11):2276–84.",
      "volume": "16",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.jmoldx.2012.06.003",
      "author": "M Chan",
      "doi-asserted-by": "publisher",
      "first-page": "602",
      "issue": "6",
      "journal-title": "J Mol Diagnostics",
      "key": "435_CR33",
      "unstructured": "Chan M, Ji SM, Yeo ZX, Gan L, Yap E, Yap YS, et al. Development of a next-generation sequencing method for BRCA mutation screening. J Mol Diagnostics. 2012;14(6):602–12.",
      "volume": "14",
      "year": "2012"
    },
    {
      "DOI": "10.1186/s13073-015-0221-8",
      "author": "NA Miller",
      "doi-asserted-by": "publisher",
      "first-page": "100",
      "issue": "1",
      "journal-title": "Genome Med",
      "key": "435_CR34",
      "unstructured": "Miller NA, Farrow EG, Gibson M, Willig LK, Twist G, Yoo B, et al. A 26-hour system of highly sensitive whole genome sequencing for emergency management of genetic diseases. Genome Med. 2015;7(1):100.",
      "volume": "7",
      "year": "2015"
    },
    {
      "DOI": "10.1186/s13073-021-00835-9",
      "author": "P Rentzsch",
      "doi-asserted-by": "publisher",
      "first-page": "31",
      "issue": "1",
      "journal-title": "Genome Med",
      "key": "435_CR35",
      "unstructured": "Rentzsch P, Schubach M, Shendure J, Kircher M. CADD-Splice—improving genome-wide variant effect prediction using deep learning-derived splice scores. Genome Med. 2021;13(1):31.",
      "volume": "13",
      "year": "2021"
    },
    {
      "DOI": "10.1093/nar/gkq603",
      "author": "K Wang",
      "doi-asserted-by": "publisher",
      "first-page": "e164",
      "issue": "16",
      "journal-title": "Nucleic Acids Res",
      "key": "435_CR36",
      "unstructured": "Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164–e164.",
      "volume": "38",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.ajhg.2017.01.004",
      "author": "Q Li",
      "doi-asserted-by": "publisher",
      "first-page": "267",
      "issue": "2",
      "journal-title": "Am J Hum Genet",
      "key": "435_CR37",
      "unstructured": "Li Q, Wang K. InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines. Am J Hum Genet. 2017;100(2):267–80.",
      "volume": "100",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.cell.2018.02.060",
      "author": "MH Bailey",
      "doi-asserted-by": "publisher",
      "first-page": "371",
      "issue": "2",
      "journal-title": "Cell",
      "key": "435_CR38",
      "unstructured": "Bailey MH, Tokheim C, Porta-Pardo E, Sengupta S, Bertrand D, Weerasinghe A, et al. Comprehensive characterization of cancer driver genes and mutations. Cell. 2018;173(2):371-385.e18.",
      "volume": "173",
      "year": "2018"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-17-0337",
      "author": "JT Robinson",
      "doi-asserted-by": "publisher",
      "first-page": "e31",
      "issue": "21",
      "journal-title": "Cancer Res",
      "key": "435_CR39",
      "unstructured": "Robinson JT, Thorvaldsdóttir H, Wenger AM, Zehir A, Mesirov JP. Variant review with the integrative genomics viewer. Cancer Res. 2017;77(21):e31–4.",
      "volume": "77",
      "year": "2017"
    },
    {
      "DOI": "10.1186/1471-2105-13-134",
      "author": "J Ye",
      "doi-asserted-by": "publisher",
      "first-page": "134",
      "issue": "1",
      "journal-title": "BMC Bioinform",
      "key": "435_CR40",
      "unstructured": "Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinform. 2012;13(1):134.",
      "volume": "13",
      "year": "2012"
    },
    {
      "author": "Y Benjamini",
      "first-page": "289",
      "issue": "1",
      "journal-title": "J R Stat Soc Ser B",
      "key": "435_CR41",
      "unstructured": "Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57(1):289–300.",
      "volume": "57",
      "year": "1995"
    }
  ],
  "reference-count": 41,
  "references-count": 41,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-022-00435-7"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Whole-exome sequencing of BRCA-negative breast cancer patients and case–control analyses identify variants associated with breast cancer susceptibility"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "16"
}